These data support Yang et al.'s findings [13], indicating that the CD25- FOXP3+ population that is expanded in SLE patients corresponds to either activated T cells or to "ex-Treg" that have lost their suppressive activity. Here, FOXP3 is linked to systemic lupus erythematosus.